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Relation of total homocysteine level with metabolic and
anthropometric variables in obese children and adolescents
Ayhan ABACI1, Ahmet Zülfikar AKELMA2, Osman ÖZDEMİR3, Şamil HIZLI4, Cem Hasan RAZİ2,
Kadir Okhan AKIN5

Aim: To evaluate the total homocysteine (tHcy) level, a risk factor for atherosclerosis, atherothrombosis, and insulin
resistance, for sex and pubertal state differences in obese children. Its relationship with metabolic and anthropometric
parameters was also investigated.
Materials and methods: The study involved obese children with a body mass index (BMI) above the 95th percentile
who presented with the complaint of excessive weight gain, and healthy children with a BMI below the 85th percentile.
Results: The study included 100 obese (mean age: 10.2 ± 2.7 years) and 71 healthy nonobese (mean age: 10.9 ± 2.6)
children. A comparison of the data from the obese group and the control group revealed that the differences in BMI,
BMI standard deviation score, tHcy, total cholesterol, triglyceride (TG), insulin, high-density lipoprotein (HDL), lowdensity lipoprotein (LDL), and homeostasis model assessment-insulin resistance (HOMA-IR) levels were statistically
significant (P < 0.05). In the obese group, the tHcy level was statistically significantly correlated with age and BMI,
TG, and HDL levels (P < 0.05), while it was not statistically significantly correlated with total cholesterol, LDL, fasting
glucose, insulin, or HOMA-IR levels (P > 0.05).
Conclusion: The results of this study showed that the tHcy level was higher in obese children than in healthy children.
However, the tHcy level was not significantly correlated with insulin resistance in obese children. Obese children should
be routinely screened for high tHcy levels due to the potential atherosclerosis risks, and patients with high tHcy levels
should be treated.
Key words: Atherosclerosis, homocysteine, insulin resistance, obesity, puberty

Obez çocuklar ve ergenlerde total homosistein düzeyinin metabolik ve
antropometrik değişkenler ile olan ilişkisi
Amaç: Obez çocuklar için ateroskleroz, aterotromboz ve insülin direnci gelişimi için risk faktörü olan total homosistein
(tHcy) düzeyini cinsiyet ve pubertal durum farklılığına göre değerlendirerek, metabolik ve antropometrik parametreler
ile olan ilişkisini araştırmak amaçlanmıştır.
Yöntem ve gereç: Çalışmaya, kilo artışı yakınması ile başvuran vücut kitle indeks (VKİ) persentili 95’in üzerinde olan
obez çocuklar ve VKİ persentili 85’in altında olan sağlıklı çocuklar alındı.
Bulgular: Çalışmaya toplam 100 obez (ortalama yaş: 10,2 ± 2,7 yıl) ve 71 sağlıklı obez olmayan (10,9 ± 2,6) çocuk
alındı. Obez grubun verileri kontrol grup ile karşılaştırıldığında VKİ, VKİ-standart sapma skoru, tHcy, total kolesterol,
trigliserit (TG), insülin, yüksek dansiteli lipoprotein (HDL), düşük dansiteli lipoprotein (LDL) ve homeostasis model
assessment-insülin direnci (HOMA-IR) düzeyleri arasında istatistiksel olarak anlamlı fark saptandı (P < 0,05). Obez
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grupta tHcy düzeyi puberte ve cinsiyet durumuna göre karşılaştırıldığında pubertedeki ve erkek hasta grubunda
istatistiksel olarak anlamlı yüksek saptandı (P < 0,05). Obez grupta tHcy düzeyi yaş, VKİ, TG ve HDL düzeyleri ile
istatistiksel olarak anlamlı korelasyon gösterdiği saptanırken (P < 0,05), total kolesterol, LDL, açlık glukoz, insülin ve
HOMA-IR düzeyi ile anlamlı korelasyon göstermediği bulundu (P > 0,05).
Sonuç: Bu çalışmanın sonuçları tHcy düzeyinin obez çocuklarda sağlıklı çocuklara göre daha yüksek olduğunu
göstermiştir. Buna karşın, tHcy düzeyinin obez çocuklarda insülin direnci ile anlamlı korelasyonunun olmadığı
bulundu. Obez çocuklarda tHcy düzeyi ateroskleroz riski nedeniyle rutin olarak taranmalıdır ve yüksek tHcy düzeyi
olan hastalar tedavi edilmelidir.
Anahtar sözcükler: Ateroskleroz, homosistein, insülin direnci, obezite, puberte

Introduction
Obesity is a chronic metabolic disease associated
with cardiovascular and atherosclerotic changes.
Its incidence among children and adolescents
has increased 3-fold in the past 20 years (1,2). In
many studies, obesity has been shown to cause
hypertension, dyslipidemia, type 2 diabetes mellitus,
and cancer (2,3).
The complications associated with obesity pave
the way for the development of atherosclerotic
pathologies. In obese individuals, various
laboratory anomalies (sensitive C-reactive protein,
interleukin-6, tumor necrosis factor, lipid profile, and
adiponectin, among others) and clinical parameters
(hypertension, intima-media thickness, hypertrophy
of the left ventricle, vascular function disorders,
and microalbuminuria) have been identified as
atherosclerosis markers (4-7). Recent studies,
particularly on adults, have suggested that elevations
in total homocysteine (tHcy) levels are important
markers for the development of atherothrombosis
and atherosclerotic changes (8-13). Furthermore,
tHcy has been found to be significantly correlated
with body mass index (BMI) and insulin resistance
(IR); it also contributes to the development of IR (1416).
The onset of atherosclerotic change is in its
infancy in obese children, and, in recent years, it has
been suggested that tHcy is one of the risk factors
(7,13,16,17). However, data on obese children are
not definitive and have remained controversial.
Thus, this study evaluated tHcy, a risk factor for
atherosclerosis, atherothrombosis, and IR, according
to sex and pubertal state differences in obese
children. In addition, the relationship of tHcy with
metabolic (lipid profile, glucose level, insulin level,
70

and IR index) and anthropometric parameters
(BMI and BMI standard deviation score (SDS)) was
investigated.
Materials and methods
The study included obese children and adolescents
with a BMI above the 95th percentile, as according
to data from the Centers for Disease Control and
Prevention (CDC), who applied to the Keçiören
Training and Research Hospital complaining of
weight gain, and healthy children and adolescents
with a BMI below the 85th percentile who were
similar in age and sex distribution to the children in
the obese group. For calculations of BMI-SDS, data
from the CDC were used (18).
Before the outset of the study, all of the patients
and control subjects were given thorough physical
examinations and laboratory tests (thyroid function
test and cortisol measurement) for potential
endocrine pathology. Those with chronic diseases that
could cause obesity (cardiovascular, gastrointestinal,
and respiratory), a history of drug use (steroids
and antipsychotics), endocrine pathology (Cushing
syndrome and hypothyroidism), or suspected
syndromes associated with obesity (Prader-Willi and
Laurence-Moon-Biedle syndromes) were excluded
from the study.
Patient height was measured using a Harpenden
stadiometer with a sensitivity of 0.1 cm, and weight
was measured using a seca scale with a sensitivity
of 0.1 kg. The weight of each subject was measured
with all clothing removed except undergarments.
BMI was calculated by dividing weight (kg) by height
squared (m2). Findings for pubertal development
were evaluated according to Tanner staging. A testes
volume of ≥4 mL in males and breast growth of stage
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2 and over (Tanner) in females were considered to be
findings of pubertal development.
The blood samples were obtained intravenously
after at least 12 h of fasting. Fasting serum glucose level
was measured using an automated analyzer (Konelab
60I, Thermo Scientific, Finland) by the enzymatic
method (Lot No. D426, Konelab). Fasting insulin
level was measured by the immunoluminometric
method (DiaSorin). Total cholesterol (TC) (Lot No.
B540, Konelab) and triglyceride (TG) (Lot No. C186,
Konelab) levels were measured by the enzymatic
calorimetric method. Low-density lipoprotein
cholesterol (LDL-C) (Lot No. C435, Konelab) and
high-density lipoprotein cholesterol (HDL-C)
(Lot No. C136, Konelab) levels were measured by
the homogenous enzymatic method. Plasma tHcy
analysis was performed using an AXSYM device
(Abbott Laboratories, Medical Diagnostics Products,
NJ, USA) and the Abbott Homocysteine Kit with
the macro-enzyme linked immunosorbent assay
(macro-ELISA) method (Abbott Laboratories).
The normal value for tHcy levels was considered to
be 3.3-11.3 μmol/L. Cutoff points above the 95th
percentile of healthy children were used to define
dyslipidemia and impaired fasting glucose, according
to international recommendations (19,20). IR was
evaluated according to the homeostasis model
assessment-insulin resistance (HOMA-IR) index.
Different cutoff values for prepubertal (HOMA-IR >
2.5) and pubertal (HOMA-IR > 4.0) stages were used
to determine the status of IR (21).
The statistical analyses of the data were conducted
with SPSS 16.0.1 (SPSS Inc., Chicago, IL, USA). All
values were presented as mean ± SD. The distribution
of data was evaluated with the KolmogorovSmirnov test. For comparisons of the groups (obese
and control; insulin-resistant and nonresistant),
Student’s t-test was used. The correlation between
the independent parameters was investigated with
Pearson’s correlation analysis. P < 0.05 was considered
statistically significant.
The study was initiated upon approval of the local
ethics committee of Keçiören Training and Research
Hospital in light of the Helsinki Declaration. The
written informed consent of the parent(s) of each
subject was also obtained before the study.

Results
The study included 100 obese (mean age: 10.2
± 2.7 years; 49 male, 41 pubertal) and 71 healthy
nonobese (mean age: 10.9 ± 2.6 years; 36 male, 35
pubertal) children. A comparison of the data from
the obese group and the control group revealed that
the differences between the BMI, BMI-SDS, tHcy,
TC, TG, insulin, HDL-C, LDL-C, fasting glucose, and
HOMA-IR levels of the 2 groups were statistically
significant (P < 0.05) (Table 1).
In the obese group, 34 (34%) children had an
elevated tHcy level, while in the control group, 9
(12.6%) children had an elevated tHcy level.
In the obese group, tHcy levels were compared
according to pubertal stage and sex and were found
to be statistically significantly higher in the pubertal
and male patients (12.8 ± 6.5 and 9.4 ± 2.9, P = 0.019;
12.6 ± 5.9 and 9.0 ± 2.9, P = 0.001, respectively).
However, in the control group, no differences were
found between the tHcy levels of pubertal and
prepubertal or between male and female subjects
(10.1 ± 2.6 and 8.7 ± 3.4, P = 0.065; 9.1 ± 2.8 and 9.7
± 3.4, P = 0.382, respectively) (Tables 2 and 3).
In the obese group, the ages of males and those
in the pubertal stage were higher than those of the
females and the subjects in the prepubertal stage
(10.8 ± 2.5 and 9.6 ± 2.7 years, P = 0.039; 12.4 ± 1.7
and 8.7 ± 2.2 years, P = 0.001, respectively).
In the comparisons of the obese cases for insulin
levels, no statistical differences were found for tHcy
levels (P > 0.05). In the obese group, the tHcy level
was statistically significantly correlated with age,
BMI, and TG and HDL-C levels (P < 0.05), while it
was not statistically significantly correlated with TC,
LDL-C, fasting glucose, insulin, or HOMA-IR levels
(P > 0.05) (Table 5).
No statistically significant differences were found
between the tHcy levels and ages of prepubertal
obese patients and prepubertal healthy children (P
> 0.05), while a statistically significant difference
was found between the 2 groups for IR and BMI (P
= 0.05) (Table 2). On the other hand, no statistically
significant age difference was noted between pubertal
obese children and pubertal healthy children (P >
0.05), whereas statistically significant differences
71
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Table 1. The clinical and laboratory characteristics of the obese and control groups (mean ± SD).
Obese group
(n = 100)

Control group
(n = 70)

P-valuea

10.2 ± 2.7

10.8 ± 2.6

0.136

BMI (kg/m )

27.6 ± 4.2

17.7 ± 2.3

0.001

BMI-SDS

2.2 ± 0.4

0.1 ± 0.7

0.001

Characteristics
Age (years)
2

10.8 ± 5.0

9.4 ± 3.1

0.041

TC (mg/dL)

tHcy (μmol/L)

162.5 ± 28.9

152.6 ± 25.3

0.022

Triglyceride (mg/dL)

129.7 ± 59.4

91.6 ± 50.7

0.001

HDL-C (mg/dL)

44.1 ± 9.9

56.0 ± 17.1

0.001

LDL-C (mg/dL)

93.5 ± 24.9

85.2 ± 17.6

0.017

Glucose (mg/dL)

89.6 ± 7.0

90.8 ± 7.6

0.306

Insulin (IU/mL)

16.0 ± 9.3

9.6 ± 5.7

0.001

HOMA-IR

3.6 ± 2.2

2.1 ± 1.28

0.001

a

Student’s t-test.
BMI: body mass index, BMI-SDS: standard deviation score of body mass index, tHcy: total homocysteine, HDL-C: high
density lipoprotein-cholesterol, HOMA-IR: homeostasis model assessment-insulin resistance, LDL-C: low density lipoproteincholesterol, TC: total cholesterol.

Table 2. The laboratory and anthropometric characteristics of the obese and control groups according to pubertal status (mean ± SD).
Prepubertal
(obese: n = 59, control: n = 36)
tHcy
Obese
Control
P*

Age
¥

9.4 ± 2.9

8.7 ± 2.9

HOMA-IR
&
β

£

3.0 ± 2.0

α

Pubertal
(obese: n = 41, control: n = 35)
BMI

tHcy
∞

26.1 ± 3.5

€

Age
¥

12.8 ± 6.5

HOMA-IR
&

12.4 ± 1.7

β

BMI

£

29.8 ± 4.1∞

α

4.5 ± 2.8

8.7 ± 3.4

9.1 ± 1.8

1.6 ± 1.0

16.9 ± 2.3

10.1 ± 2.6

12.6 ± 2.0

2.6 ± 1.3

18.5 ± 2.1€

0.300

0.344

0.001

0.001

0.027

0.633

0.001

0.001

*, ¥, £, ∞, β, α, €

: P < 0.05 (Student’s t-test).
BMI: body mass index, tHcy: total homocysteine, HOMA-IR: homeostasis model assessment-insulin resistance.

were found between the tHcy, IR, and BMI values of
the 2 groups (P < 0.05) (Table 2).
The tHcy levels, ages, and HOMA-IR and BMI
results of the pubertal obese patients and prepubertal
obese patients were statistically significantly different
(P < 0.05); however, comparisons of the pubertal and
prepubertal children in the control group showed
no differences between the tHcy levels. The ages and
the IR and BMI results of these groups (pubertal and
prepubertal controls) were statistically significantly
different (P < 0.05) (Table 2).
In 47 (47%) of obese patients and in 11 (15.5%) of
the control subjects, IR was detected. Comparisons
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of the children in the obese group for HOMAIR presence showed that there were statistically
significant differences between the age and BMI
values of the children with HOMA-IR and the
children without HOMA-IR; however, no statistically
significant difference was found between the groups
for tHcy levels (11.1 ± 4.1 and 10.5 ± 5.6, P = 0.60,
respectively) (Table 4).
While in the obese group, the tHcy level was
significantly correlated with age, BMI, and TG
and HDL-C levels (P < 0.05), no correlations were
determined between tHcy and TC, LDL-C, fasting
glucose, insulin, and HOMA-IR levels (P > 0.05). In
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Table 3. The clinical and laboratory characteristics of the obese and control groups according to sex (mean ± SD).
Obese group
Characteristics

Control group

Male
(n = 49)

Female
(n = 51)

Pa

Male
(n = 36)

Female
(n = 35)

Pa

10.8 ± 2.5

9.6 ± 2.7

0.039

11.0 ± 2.6

10.6 ± 2.5

0.452

BMI (kg/m )

28.5 ± 3.9

26.8 ± 4.2

0.181

17.9 ± 2.2

17.5 ± 2.4

0.464

BMI-SDS

2.3 ± 0.5

2.2 ± 0.4

0.230

0.07 ± 0.7

–0.1 ± 0.9

0.467

tHcy (μmol/L)

12.6 ± 5.9

9.0 ± 2.9

0.001

9.1 ± 2.8

9.7 ± 3.4

0.382

TC (mg/dL)

162 ± 28

162 ± 29

0.956

156 ± 24

148 ± 25

0.166

Triglyceride (mg/dL)

141 ± 62

118 ± 54

0.047

84 ± 52

99 ± 48

0.198

HDL-C (mg/dL)

42 ± 9

45 ± 10

0.069

55 ± 12

56 ± 20

0.853

LDL-C (mg/dL)

94 ± 23

92 ± 26

0.734

87 ± 18

83 ± 17

0.334

Glucose (mg/dL)

90.5 ± 6.8

88.8 ± 7.2

0.227

92.5 ± 7.2

89 ± 7.7

0.053

Insulin (IU/mL)

16.0 ± 9.4

15.1 ± 9.15

0.326

9.3 ± 5.7

9.7 ± 5.8

0.680

HOMA-IR

3.9 ± 2.3

3.3 ± 2.0

0.256

2.1 ± 1.3

2.1 ± 1.2

0.965

Age (years)
2

a

Student’s t-test.
BMI: body mass index, BMI-SDS: standard deviation score of body mass index, tHcy: total homocysteine, HDL-C: high density
lipoprotein-cholesterol, HOMA-IR: homeostasis model assessment-insulin resistance, LDL-C: low density lipoprotein-cholesterol, TC:
total cholesterol.

Table 4. The clinical and laboratory characteristics of the obese group with and without insulin resistance (mean ± SD).
With insulin
resistance (n = 47)

Without insulin
resistance (n = 53)

Pa

Age (years)

11.0 ± 2.5

9.6 ± 2.7

0.006

BMI (kg/m2)

29.2 ± 3.83

26.2 ± 4.0

0.001

BMI-SDS

2.28 ± 0.4

2.17 ± 0.5

0.230

tHcy (μmol/L)

11.1 ± 4.1

10.54 ± 5.6

0.600

TC (mg/dL)

167.5 ± 28.5

157.9 ± 28.8

0.096

Triglyceride (mg/dL)

142.5 ± 62.6

118.2 ± 54.5

0.041

HDL-C (mg/dL)

44.8 ± 9.5

46.2 ± 9.9

0.026

LDL-C (mg/dL)

98.9 ± 23.4

88.8 ± 25.5

0.042

Glucose (mg/dL)

90.6 ± 8.0

88.8 ± 5.9

0.193

Insulin (IU/mL)

16.0 ± 9.3

9.6 ± 5.7

0.001

HOMA-IR

5.3 ± 2.1

2.1 ± 0.9

0.001

a

Student’s t-test.
BMI: body mass index, BMI-SDS: standard deviation score of body mass index, tHcy: total homocysteine, HDL-C:
high density lipoprotein-cholesterol, HOMA-IR: homeostasis model assessment-insulin resistance, LDL-C: low density
lipoprotein-cholesterol, TC: total cholesterol.
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Table 5. The correlations between total homocysteine level and clinical laboratory parameters of the obese and control groups.
Obese group

Control group

r

Pa

r

Pa

Age (years)

0.449

0.001

0.340

0.040

BMI (kg/m2)

0.374

0.001

0.138

0.258

BMI-SDS

−0.028

0.782

−0.085

0.479

Triglyceride (mg/dL)

0.293

0.003

−0.103

0.397

TC (mg/dL)

−0.089

0.381

−0.126

0.296

LDL-C (mg/dL)

−0.081

0.421

−0.226

0.058

HDL-C (mg/dL)

−0.289

0.040

−0.027

0.825

Glucose (mg/dL)

−0.163

0.105

−0.168

0.162

Insulin (IU/mL)

0.188

0.061

−0.041

0.733

HOMA-IR

0.150

0.138

−0.017

0.888

a

Pearson’s correlation analysis.
BMI: body mass index, BMI-SDS: standard deviation score of body mass index, tHcy: total homocysteine, HDL-C: high density
lipoprotein-cholesterol, HOMA-IR: homeostasis model assessment-insulin resistance, LDL-C: low density lipoprotein-cholesterol, TC:
total cholesterol.

the control group, the tHcy level was only significantly
correlated with age (P < 0.05) (Table 5).
Discussion
Homocysteine is normally a sulfur amino acid
that is formed by the transmethylation of methionine
amino acid. It can retransform into methionine
amino acid by remethylation, accompanied by folate
and vitamin B12, as well as into cysteine amino
acid by cystathionine-β-synthase enzyme mediated
with vitamin B6. The pathology that develops due
to cystathionine-β-synthase enzyme deficiency
is associated with premature atherosclerosis and
recurrent thromboembolic events in homocystinuria.
In addition, nutritional (folic acid and vitamins B6 and
B12), genetic (methylenetetrahydrofolate reductase
gene mutations), and endocrine factors, as well as
cancer, human immunodeficiency virus, and renal
failure, have been claimed as conditions responsible
for moderately high levels of tHcy (22,23). Childhood
obesity, accompanied by nutritional deficiencies and
endocrine disorders, is one of the important chronic
metabolic diseases. In recent years, controversial
results regarding the association between obesity
and tHcy level have been reported. Moreover, tHcy
level has been reported to vary according to age, sex,
74

and pubertal status in healthy, obese, and diabetic
children (22,24,25).
Brasileiro et al., in their study on overweight
and healthy pubertal children, found no statistically
significant differences between the tHcy levels of 86
overweight and 153 healthy children (24). Papandreou
et al. evaluated school children, 6-15 years of age, and
determined no statistically significant differences
between the tHcy levels of obese (n = 41), overweight
(n = 102), and healthy (n = 381) children regardless
of their pubertal stage (26). Similarly, Martos et al.
did not find any statistically significant difference
between the tHcy levels of prepubertal obese children
(n = 43) and nonobese children (n = 43) who were
6-9 years of age (13). On the other hand, in a study
by Ustundag et al., the tHcy levels of 60 prepubertal
obese children were statistically higher than those of
the 60 children in the control group (27). Likewise,
Narin et al. reported significantly higher levels of
tHcy in obese children than in the control group
(aged 7-17 years), regardless of pubertal stage (28).
In our study, the tHcy levels of obese children were
statistically higher than those of healthy children.
In the literature, tHcy level has been reported to
vary depending on age, sex, IR, and pubertal status
(22,24,25). It has also been shown to positively
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correlate with age and sex in healthy children (22,24).
In their study on healthy children, De Laet et al.
determined that the tHcy level of the adolescents,
15-19 years of age, was higher than that of the
children, 5-9 years of age (22). In the same study, a
comparison by sex of healthy children, 15-19 years
of age, showed that the tHcy level was statistically
significantly higher in the males than in the females.
Brasileiro et al. determined a correlation between
tHcy level and age and sex in the control subjects
and overweight children (24). In our study, the tHcy
level was significantly correlated with age, in both the
control and obese groups, and the male subjects had
significantly higher tHcy levels than female subjects
in the obese group.
Although no differences in tHcy levels were
reported in obese children for different pubertal
stages, in a study of type I diabetes mellitus patients,
the level of tHcy was significantly correlated with
pubertal stage (25). In addition to a lack of difference
by age, in our study we found that tHcy levels
of children in the prepubertal obese and control
groups were not statistically significantly different,
while tHcy levels of children in the pubertal obese
and control groups were statistically significantly
different. Moreover, in the comparison of the tHcy
levels of the prepubertal obese and control groups,
the tHcy levels of the control group did not differ in a
statistically significant manner according to age, IR,
or BMI. In the obese pubertal patients, however, the
tHcy levels were statistically significantly higher than
those of the prepubertal obese patients. These results
support the finding that, in addition to the factors
that affect tHcy level, such as age, BMI, and IR,
nutritional status in pubertal obese patients is more
disordered than in the prepubertal obese patients.
Obesity is one of the important markers of
unhealthy and imbalanced nutrition. Folate and
vitamin B12 deficiencies have been reported to be
the most important causes of elevated tHcy levels
(24,29). Brasileiro et al. determined folate deficiency
in 68.6% of overweight children with elevated tHcy
levels and emphasized deficiencies in vitamin B12
and folate, which are usually supplied in the daily
diet (24). Lin et al. showed a significant negative
correlation between folate and vitamin B12 level and
tHcy level (29). However, in our study, the dietary

habits of the patients were not investigated in detail,
and vitamin B12 and folate levels were not studied;
this is a drawback of the current study.
In the literature, tHcy level has been reported to
be associated with insulin levels in obese individuals
(13). Nevertheless, whether IR leads to increases
in tHcy levels or elevated tHcy levels lead to IR
remains controversial (14). In a study by Martos
et al. of children of 6-9 years of age, the tHcy levels
of hyperinsulinemic obese subjects (n = 14) were
significantly higher than levels in normoinsulinemic
obese subjects (n = 29) and were shown to be
significantly correlated with fasting glucose and
HOMA-IR levels (13). In our study, which had a
larger number of participants, the tHcy levels of the
obese patients with IR (n = 47) were higher than those
of the obese patients without IR (n = 53); however,
the difference was not statistically significant.
Moreover, in the obese group, the tHcy level was not
significantly correlated with HOMA-IR or fasting
glucose levels. These findings show that there is no
significant correlation between tHcy level and IR.
The results of this study show that the tHcy levels
of obese and healthy children differ depending on
age, sex, and pubertal status, but that these levels are
not correlated with IR. In addition, the tHcy levels
of obese adolescents in the pubertal stage are higher
than the levels in prepubertal obese children. Obese
children should be routinely screened for high tHcy
levels due to the potential risk of atherosclerosis, and
patients with high tHcy levels should be treated to
prevent prospective vascular pathologies.
Conclusion
Based on the findings of this study, it can be
emphasized that, to prevent potential cardiovascular
diseases in pubertal (adolescent) obese children
and prepubertal obese children, the dietary habits
and nutritional intake of these children should be
improved according to the needs of the age group,
and preventive health measures should be taken to
avoid or overcome obesity.
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